SAGILITY (SAGILITY)
Active threads
Sagility shares fall 6% as promoter sells ₹2,543 crore stake
Sagility share price drops 6% after promoter likely to have sold equity worth ₹2,543 crore - Published OnOct 30, 2026 | 10:01 IST - Last Updated OnOct 30, 2026 | 10:01 IST In case Sagility B.V. is indeed the seller in the transaction, their holdings will drop below 50% after this deal, as they held a 50.95% stake in the company at the end of the September quarter. fell as much as 6% on Friday, October 30, after a large trade took place in the stock a few minutes after market opening.
Sagility Q2 net profit rises 13% to ₹284 crore
Sagility Q2 Results: Net profit up 13% on 23% revenue growth; declares dividend - Published OnOct 22, 2026 | 19:06 IST - Last Updated OnOct 22, 2026 | 19:06 IST Sagility Ltd reported a 13.1% rise in Q2 FY27 net profit to ₹284 crore and a 22.6% increase in revenue to ₹2,032 crore. EBITDA grew 23.4% to ₹512 crore with a flat margin of 25%. The board declared an interim dividend of ₹0.15 per equity share, citing strong operating leverage and disciplined execut...
Sagility BV to offload 12% stake for ₹2,377 crore via block deal
Promoter Sagility BV is set to sell a 12% stake in Sagility through a block deal valued at ₹2,377 crore. The floor price for the transaction has been set at ₹42.45 per share, according to CNBC TV18. The sale marks a significant promoter-level dilution in the company.
JPMorgan rates Sagility Buy, sees 31% upside on Chirok Health deal
Sagility's Chirok Health Acquisition can boost its stock price by 31%, JPMorgan says - Published OnOct 22, 2026 | 12:54 IST - Last Updated OnOct 22, 2026 | 12:54 IST JPMorgan issued a buy rating on Sagility with a target price of ₹58, signaling a potential 31% upside. The bullish outlook is driven by the strategic acquisition of US-based Chirok Health, which expands Sagility's provider segment portfolio, enhances its addressable market, and is expected to be mar...
Intelligence feed
No articles in the last 24 hours.